GENEO Capital Entrepreneur
GENEO Capital Entrepreneur is a French private equity firm founded in 2019, managing an evergreen fund with €740 million under management, dedicated to supporting the long-term growth and transfer of SMEs and ETIs through tailor-made capital and operational support.
GENEO Capital Entrepreneur is a PARIS growth equity firm with €740M AUM, 34 active companies and 3 exits.
- ·3 exits in the last 5 years · consistent DPI cadence.
- ·Average hold across 3 realized deals: 5 years.
- ·Top sector focus: Business Services (30% of portfolio).
- ·Fund cadence: ~3Y between vintages · last raise 2022.
Sector breakdown
37 companiesKey facts
Recent exits
GENEO Capital Entrepreneur sold Wirun to LFPI in 2026 after 4 years.
GENEO Capital Entrepreneur sold Convictions RH to Mercer (Marsh McLennan) in 2025 after 5 years.
GENEO Capital Entrepreneur sold Human and Work to Telus Sante (Telus Corporation) in 2024 after 5 years.
Coverage notes
2 funds tracked, 37 portfolio companies (34 active · 3 realized). Verified weekly from public filings and deal announcements.
Funds & portfolio
Every fund GENEO Capital Entrepreneur has raised, with its portfolio companies. Hand-checked from public filings.
GENEO MezzanineinvestingPrivate Debt2022€140M7 assetsPrivate Debt2022 · 4yr€140M7–
GENEO CapitalharvestingGrowth2019€600M27 assets3 exitsGrowth2019 · 7yr€600M273
Unrealized
27 held| Company | Entry |
|---|---|
| ACS Financials · France | 2024 |
| Acteo Industrials · France | 2023 |
| BBL Group Logistics · France | 2020 |
| ChapsVision Software · France | 2023 |
| Coverpla Industrials · France | 2024 |
| Didactic MedTech · France | 2024 |
| DSL Business Services · France | 2021 |
| Egis Business Services · France | 2023 |
| Enygea Business Services · France | 2022 |
| G.a.c Group Business Services · France | 2022 |
| GBNA Polycliniques Healthcare · France | 2021 |
| Hoppen HealthTech · France | 2019 |
| Kardham Business Services · France | 2020 |
| Kinougarde Complétude Business Services · France | 2021 |
| Leader Group Industrials · France | 2021 |
| Magiline Industrials · France | 2021 |
| Neftys-pharma Pharma · France | 2022 |
| Odigo TMT · France | 2022 |
| Otego Industrials · France | 2020 |
| Pinette PEI Industrials · France | 2019 |
| Safic-Alcan Industrials · France | 2022 |
| Scutum Business Services · France | 2023 |
| Seiven Consumer · France | 2025 |
| Sterimed MedTech · France | 2025 |
| Valtus Business Services · France | 2020 |
| XEFI Telecom · France | 2022 |
| Zurflüh-Feller Construction · France | 2022 |
Realized
3 exits| Company | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|
| Convictions RH Business Services · France | 2020 | 2025 | Trade Sale | Mercer (Marsh McLennan) | – |
| Human and Work Business Services · France | 2019 | 2024 | Trade Sale | Telus Sante (Telus Corporation) | – |
| Wirun Consumer · France | 2022 | 2026 | Secondary | LFPI | – |
About GENEO Capital Entrepreneur
GENEO Capital Entrepreneur is a French private equity firm with €740 million of assets under management as of December 2024, founded in 2019 and headquartered in Paris. The firm manages an evergreen fund dedicated to supporting the long-term growth and transfer of French SMEs, distinguishing the platform with the evergreen permanent capital structure aligned with patient capital and management transition scenarios.
Investment thesis
GENEO targets French SMEs and mid-cap companies seeking patient capital for growth, succession or management buyout scenarios, with the evergreen fund structure enabling long-duration positions unconstrained by traditional fund cycles. Sector focus spans Business Services, Industrials and Healthcare, with the platform emphasising operational partnership and patient capital deployment alongside owner-operator management teams.
Recent activity
Recent realised exits include Convictions RH (business services, 2025), Human and Work (business services, 2024) and Zurflüh-Feller (industrials, 2022), reflecting selective distribution across the evergreen portfolio. The platform tracks 2 funds and 26 active portfolio companies across the long-duration French SME programme.
Portfolio platforms backed by GENEO Capital Entrepreneur made 8 researched add-on acquisitions during its ownership.
Frequently asked questions
- What investment strategy does GENEO Capital Entrepreneur focus on?
- GENEO Capital Entrepreneur focuses on Growth, Buyout strategies in the private equity space.
- How many portfolio companies does GENEO Capital Entrepreneur have?
- GENEO Capital Entrepreneur has 34 active portfolio companies and 3 completed exits and 2 funds tracked on GP Intel.
- Where is GENEO Capital Entrepreneur headquartered?
- GENEO Capital Entrepreneur is headquartered in PARIS, France.
- What is GENEO Capital Entrepreneur's assets under management?
- GENEO Capital Entrepreneur manages approximately €740M in assets under management.
- When was GENEO Capital Entrepreneur founded?
- GENEO Capital Entrepreneur was founded in 2018.
- What sectors does GENEO Capital Entrepreneur invest in?
- GENEO Capital Entrepreneur invests across Business Services, Industrials.
- What are GENEO Capital Entrepreneur's recent exits?
- Recent realized exits by GENEO Capital Entrepreneur include: Wirun (2026) to LFPI; Convictions RH (2025) to Mercer (Marsh McLennan); Human and Work (2024) to Telus Sante (Telus Corporation).
Similar firms
Other private equity firms tracked on GP Intel.
France·€750M
France·€704M
France·€700M
France·€700M
France·€780M
France·€800M
France·€800M
France·€800M
France·€800MFrance·€820M
France·€650M
France·€650M